Datasets:

anthonyyazdaniml
/

gliner-biomed-pre-training

tokenized_text listlengths 6 2.61k	ner listlengths 0 194
[ "The", "present", "invention", "provides", "a", "human", "papilloma", "virus", "16", "type", "L1", "protein", "HPV16L1", "-", "g", "and", "a", "coding", "gene", "and", "application", "thereof", ".", "The", "amino", "acid", "sequence", "of", "the", "HPV16L1",...	[ [ 5, 14, "Protein" ], [ 17, 18, "Gene" ], [ 44, 45, "Gene" ], [ 24, 26, "Sequence" ], [ 36, 40, "Identifier" ], [ 65, 70, "Vector" ], [ 84, 84, "Property" ], [ 87, 89, "Risk" ], [ 93, ...
[ "Ankle", "sprain", "is", "the", "most", "common", "type", "of", "ankle", "injury", ",", "comprising", "nearly", "80", "%", "of", "all", "injuries", "affecting", "this", "area", ".", "Among", "these", ",", "77", "%", "consists", "of", "sprains", "involving"...	[ [ 0, 1, "Condition" ], [ 62, 63, "Condition" ], [ 306, 307, "Condition" ], [ 345, 346, "Condition" ], [ 489, 490, "Condition" ], [ 542, 543, "Condition" ], [ 680, 681, "Condition" ], [ 700, 701, ...
[ "Eligible", "subjects", "will", "receive", "single", "dose", "of", "paroxetine", "25", "milligrams", "controlled", "release", "formulation", "followed", "by", "wash", "-", "out", "period", "of", "5", "days", ".", "Subjects", "will", "receive", "multiple", "doses...	[ [ 0, 1, "Study subject" ], [ 4, 5, "Dosage" ], [ 7, 7, "Drug" ], [ 29, 29, "Drug" ], [ 8, 9, "Dosage strength" ], [ 30, 31, "Dosage strength" ], [ 10, 12, "Drug formulation" ], [ 15, 18, "Stud...
[ "Multi", "-", "state", "survival", "models", "are", "used", "to", "represent", "the", "natural", "history", "of", "a", "disease", ",", "forming", "the", "basis", "of", "a", "health", "technology", "assessment", "comparing", "a", "novel", "treatment", "to", "...	[ [ 0, 4, "Statistical model" ], [ 10, 14, "Concept" ], [ 21, 23, "Assessment tool" ], [ 26, 27, "Intervention" ], [ 29, 30, "Intervention" ], [ 36, 37, "Condition" ], [ 42, 43, "Data source" ], [ 69, ...
[ "The", "mechanism", "of", "action", "and", "key", "technology", "of", "the", "drug", "of", "the", "present", "invention", "are", "summarized", "in", "figure", "1", ".", "Specifically", ",", "malignant", "misfolded", "proteins", "such", "as", "mutant", "hunting...	[ [ 9, 13, "Drug" ], [ 22, 24, "Protein" ], [ 27, 28, "Protein" ], [ 30, 32, "Protein" ], [ 289, 291, "Protein" ], [ 38, 39, "Aggregates" ], [ 46, 47, "Aggregates" ], [ 54, 55, "Aggregates" ],...
[ "FIELD", ":", "medicine", ".", "^", "SUBSTANCE", ":", "invention", "refers", "to", "biotechnology", ".", "The", "pharmaceutical", "composition", "for", "destruction", "of", "tumor", "cells", "expressing", "the", "receptor", "CCR7", "is", "described", ",", "which...	[ [ 2, 2, "Field" ], [ 10, 10, "Field" ], [ 13, 14, "Substance" ], [ 18, 19, "Cell type" ], [ 49, 50, "Cell type" ], [ 22, 23, "Receptor" ], [ 34, 35, "Receptor" ], [ 53, 54, "Receptor" ], [...
[ "Particles", "of", "a", "(", "primary", ")", "oil", "-", "in", "-", "hydrophilic", "liquid", "emulsion", "containing", "a", "thickening", "agent", "in", "the", "hydrophilic", "liquid", "phase", "are", "encapsulated", "by", "forming", "a", "secondary", "emulsio...	[ [ 6, 12, "Emulsion" ], [ 15, 16, "Component" ], [ 19, 21, "Phase" ], [ 27, 28, "Emulsion" ], [ 32, 33, "Emulsion" ], [ 82, 83, "Emulsion" ], [ 281, 282, "Emulsion" ], [ 37, 38, "Medium" ], ...
[ "Placebo", "is", "administered", "once", "daily", "by", "subcutaneous", "injections", "with", "the", "pen", "-", "injector", ",", "either", "in", "the", "abdomen", ",", "thigh", "or", "upper", "arm", ".", "Injections", "can", "be", "done", "at", "any", "ti...	[ [ 0, 0, "Drug" ], [ 44, 44, "Drug" ], [ 3, 4, "Frequency" ], [ 6, 7, "Route of administration" ], [ 10, 12, "Device" ], [ 17, 17, "Location" ], [ 19, 19, "Location" ], [ 21, 22, "Location" ]...
[ "This", "invention", "pertains", "to", "a", "multi", "-", "layered", "tablet", "for", "a", "triple", "combination", "release", "of", "active", "agents", "to", "an", "environment", "of", "use", ".", "More", "particularly", ",", "the", "invention", "pertains", ...	[ [ 5, 8, "Drug delivery system" ], [ 31, 34, "Drug delivery system" ], [ 11, 13, "Drug release mechanism" ], [ 71, 73, "Drug release mechanism" ], [ 15, 16, "Drug" ], [ 19, 21, "Location" ], [ 40, 44, "Compone...
[ "Fentanyl", "is", "metabolized", "mainly", "via", "the", "human", "cytochrome", "P450", "3A4", "isoenzyme", "system", "(", "CYP3A4", ")", ";", "therefore", "potential", "interactions", "may", "occur", "when", "OTFC", "is", "given", "concurrently", "with", "agent...	[ [ 0, 0, "Drug" ], [ 86, 86, "Drug" ], [ 142, 142, "Drug" ], [ 7, 14, "Enzyme system" ], [ 22, 22, "Drug product" ], [ 37, 37, "Drug product" ], [ 103, 103, "Drug product" ], [ 167, 167, "Drug ...
[ "#", "#", "#", "Adenomatous", "Polyp", "Prevention", "Studies", "(", "NCT00005094", "and", "NCT00141193", ")", "\n\n", "Cardiovascular", "safety", "was", "evaluated", "in", "two", "randomized", ",", "double", "-", "blind", ",", "placebo", "-", "controlled", ",...	[ [ 3, 6, "Clinical trial" ], [ 8, 8, "Clinical trial ID" ], [ 10, 10, "Clinical trial ID" ], [ 40, 40, "Drug" ], [ 49, 49, "Drug" ], [ 92, 92, "Drug" ], [ 161, 161, "Drug" ], [ 177, 177, "Drug"...
[ "This", "study", "includes", "ASA", "I", "-", "II", "patients", "aged", "18", "-", "65", "years", "who", "will", "undergo", "Anterior", "Cervical", "Disc", "and", "Fusion", "Surgery", "at", "C5", "or", "C6", "level", "under", "general", "anesthesia", "unde...	[ [ 3, 7, "Patient group" ], [ 9, 12, "Age range" ], [ 16, 21, "Surgical procedure" ], [ 23, 26, "Surgical site" ], [ 28, 29, "Anesthesia type" ], [ 31, 32, "Surgical indication" ], [ 50, 51, "Study group" ],...
[ "The", "present", "invention", "is", "directed", "to", "a", "method", "of", "reducing", "intraocular", "pressure", ".", "The", "method", "comprises", "administering", "to", "a", "subject", "a", "pharmaceutical", "composition", "comprising", "an", "effective", "amo...	[ [ 7, 7, "Entity" ], [ 14, 14, "Entity" ], [ 43, 43, "Entity" ], [ 72, 72, "Entity" ], [ 83, 83, "Entity" ], [ 9, 11, "Goal" ], [ 21, 22, "Entity" ], [ 19, 19, "Entity" ], [ 56, 57,...
[ "A", "non", "-", "transitory", "computer", "readable", "storage", "medium", "has", "instructions", "executed", "by", "a", "processor", "to", "prompt", "a", "user", "for", "personal", "information", ".", "The", "user", "is", "prompted", "to", "take", "a", "se...	[ [ 1, 7, "Data storage" ], [ 9, 9, "Software code" ], [ 13, 13, "Hardware component" ], [ 17, 17, "Person" ], [ 23, 23, "Person" ], [ 34, 34, "Person" ], [ 43, 43, "Person" ], [ 55, 55, "Person...
[ "Fulvestrant", "500", "mg", "IM", "D1", ",", "D15", ",", "then", "D1", "of", "every", "28", "day", "cycle", "Placebo", "po", "daily", "Clinician", "review", "D1", ",", "D15", ",", "weeks", "4", ",", "8", ",", "12", ",", "16", ",", "20", ",", "24"...	[ [ 0, 0, "Drug" ], [ 1, 2, "Dosage" ], [ 3, 3, "Route of administration" ], [ 4, 4, "Day" ], [ 9, 9, "Day" ], [ 20, 20, "Day" ], [ 6, 6, "Day" ], [ 22, 22, "Day" ], [ 9, 14, "Fr...
[ "AIMS", ":", "Cardiac", "fibrosis", "is", "characterized", "by", "aberrant", "collagen", "deposition", "in", "the", "heart", ".", "Macrophage", "polarization", "or", "infiltration", "is", "the", "main", "reason", "to", "accelerate", "the", "collagen", "deposition"...	[ [ 2, 3, "Condition" ], [ 42, 43, "Condition" ], [ 50, 51, "Condition" ], [ 150, 151, "Condition" ], [ 160, 161, "Condition" ], [ 204, 205, "Condition" ], [ 8, 9, "Pathological process" ], [ 25, 26...
[ "BACKGROUND", ":", "Women", "are", "more", "likely", "to", "experience", "multiple", "overlapping", "pain", "conditions", "(", "MOPCs", ")", "relative", "to", "men", ".", "Post", "-", "traumatic", "stress", "disorder", "can", "negatively", "impact", "the", "se...	[ [ 2, 2, "Demographic group" ], [ 172, 172, "Demographic group" ], [ 180, 180, "Demographic group" ], [ 333, 333, "Demographic group" ], [ 358, 358, "Demographic group" ], [ 17, 17, "Demographic group" ], [ 196, 1...
[ "Recombinant", "respiratory", "syncytial", "virus", "(", "RSV", ")", "having", "the", "position", "of", "genes", "shifted", "within", "the", "genome", "or", "antigenome", "of", "the", "recombinant", "virus", "are", "infectious", "and", "attenuated", "in", "human...	[ [ 0, 6, "Virus" ], [ 11, 11, "Genetic material" ], [ 44, 44, "Genetic material" ], [ 127, 127, "Genetic material" ], [ 171, 171, "Genetic material" ], [ 180, 180, "Genetic material" ], [ 219, 219, "Genetic ma...
[ "Diagnostic", "colonoscopy", "will", "be", "performed", "in", "all", "patients", ".", "If", "a", "polyp", ",", "appropriate", "for", "inclusion", "criteria", ",", "is", "identified", ",", "an", "endoscopic", "polypectomy", "will", "be", "assigned", ".", "All",...	[ [ 0, 1, "Procedure" ], [ 11, 11, "Condition" ], [ 111, 111, "Condition" ], [ 15, 16, "Criteria" ], [ 22, 23, "Procedure" ], [ 39, 40, "Procedure" ], [ 44, 46, "Procedure" ], [ 48, 50, "Procedu...
[ "Transaminase", "elevations", "have", "been", "observed", "in", "healthy", "volunteers", "who", "received", "200", "mg", "of", "VEKLURY", "followed", "by", "100", "mg", "doses", "for", "up", "to", "10", "days", ";", "the", "transaminase", "elevations", "were",...	[ [ 0, 1, "Adverse event" ], [ 26, 27, "Adverse event" ], [ 49, 50, "Adverse event" ], [ 72, 73, "Adverse event" ], [ 107, 108, "Adverse event" ], [ 6, 7, "Study group" ], [ 13, 13, "Drug" ], [ 47, ...
[ "Vial", "and", "contents", "must", "be", "discarded", "30", "days", "after", "initial", "use", ".", "\n\n", "Store", "between", "20", "°", "to", "25", "°", "C", "(", "68", "°", "to", "77", "°", "F", ")", "[", "See", "USP", "Controlled", "Room", "Te...	[ [ 0, 2, "Drug product" ], [ 6, 7, "Duration" ], [ 9, 10, "Event" ], [ 15, 35, "Storage condition" ], [ 37, 37, "Drug" ], [ 39, 40, "Property" ], [ 46, 46, "Condition to avoid" ], [ 52, 53, "Co...
[ "Medicament", "composition", "(", "A", ")", "contains", "a", "nucleotide", "sequence", "(", "I", ")", "including", "at", "least", "one", "open", "reading", "frame", "showing", "homology", "(", "or", "hybridizing", ")", "with", "at", "least", "one", "segment"...	[ [ 0, 4, "Composition" ], [ 71, 75, "Composition" ], [ 7, 11, "Sequence" ], [ 78, 82, "Sequence" ], [ 16, 18, "Sequence feature" ], [ 87, 89, "Sequence feature" ], [ 20, 20, "Relationship" ], [ 104, ...
[ "Handling", ":", "ARRANON", "is", "a", "cytotoxic", "agent", ".", "Caution", "should", "be", "used", "during", "handling", "and", "preparation", ".", "Use", "of", "gloves", "and", "other", "protective", "clothing", "to", "prevent", "skin", "contact", "is", "...	[ [ 2, 2, "Drug" ], [ 56, 56, "Drug" ], [ 64, 64, "Drug" ], [ 116, 116, "Drug" ], [ 5, 6, "Drug property" ], [ 19, 19, "Personal protective equipment" ], [ 22, 23, "Personal protective equipment" ], [ 3...
[ "Study", "1", "was", "an", "open", "-", "label", ",", "2", "-", "part", "study", "to", "investigate", "the", "efficacy", ",", "safety", ",", "pharmacokinetics", ",", "and", "pharmacodynamics", "of", "EVRYSDI", "in", "patients", "with", "Type", "1", "SMA", ...	[ [ 0, 1, "Clinical trial" ], [ 75, 76, "Clinical trial" ], [ 89, 90, "Clinical trial" ], [ 424, 425, "Clinical trial" ], [ 24, 24, "Drug" ], [ 97, 97, "Drug" ], [ 419, 419, "Drug" ], [ 28, 30, ...
[ "Safety", "and", "effectiveness", "in", "the", "pediatric", "population", "other", "than", "pediatric", "patients", "with", "OCD", "have", "not", "been", "established", "(", "see", "BOX", "WARNING", "and", "WARNINGS", ",", "Clinical", "Worsening", "and", "Suicid...	[ [ 36, 36, "Drug" ], [ 74, 74, "Drug" ], [ 89, 89, "Drug" ], [ 161, 161, "Drug" ], [ 183, 183, "Drug" ], [ 225, 225, "Drug" ], [ 248, 248, "Drug" ], [ 307, 307, "Drug" ], [ 5, 6, ...
[ "The", "study", "will", "be", "a", "novel", "investigation", "that", "elucidates", "the", "current", "state", "by", "comparing", "core", "muscle", "function", "outcomes", "with", "the", "type", "and", "severity", "of", "symptoms", "in", "children", "with", "lo...	[ [ 14, 16, "Outcome measure" ], [ 28, 31, "Condition" ], [ 59, 62, "Condition" ], [ 73, 76, "Condition" ], [ 189, 192, "Condition" ], [ 203, 206, "Condition" ], [ 26, 26, "Population" ], [ 57, 57, ...
[ "The", "safety", "and", "efficacy", "of", "OXYCONTIN", "have", "been", "established", "in", "pediatric", "patients", "ages", "11", "to", "16", "years", ".", "Use", "of", "OXYCONTIN", "is", "supported", "by", "evidence", "from", "adequate", "and", "well", "-"...	[ [ 5, 5, "Drug" ], [ 20, 20, "Drug" ], [ 33, 33, "Drug" ], [ 87, 87, "Drug" ], [ 128, 128, "Drug" ], [ 10, 11, "Patient group" ], [ 45, 46, "Patient group" ], [ 89, 90, "Patient group" ], [...
[ "People", "with", "dementia", "often", "have", "fragmented", "night", "-", "time", "sleep", ",", "prolonged", "night", "-", "time", "awakenings", "and", "increased", "daytime", "sleep", ".", "Behavioural", "and", "psychological", "symptoms", "of", "dementia", "(...	[ [ 2, 2, "Condition" ], [ 26, 26, "Condition" ], [ 83, 83, "Condition" ], [ 98, 98, "Condition" ], [ 143, 143, "Condition" ], [ 169, 169, "Condition" ], [ 289, 289, "Condition" ], [ 6, 9, "Symp...
[ "Some", "patients", "accidentally", "taking", "600", "mg", "twice", "daily", "have", "reported", "increased", "nervous", "system", "symptoms", ".", "One", "patient", "experienced", "involuntary", "muscle", "contractions", ".", "\n\n", "Treatment", "of", "overdose", ...	[ [ 27, 27, "Drug" ], [ 71, 71, "Drug" ], [ 74, 74, "Drug" ], [ 4, 5, "Dosage" ], [ 6, 7, "Frequency" ], [ 11, 13, "Adverse effect" ], [ 18, 20, "Adverse effect" ], [ 31, 33, "Treatment" ], ...
[ "For", "each", "PWD", ",", "1", "non", "-", "disabled", "control", "person", "will", "be", "randomly", "chosen", "from", "the", "census", "list", "of", "the", "same", "enumeration", "area", ".", "Control", "will", "also", "be", "matched", "on", "age", "a...	[ [ 2, 2, "Study group" ], [ 5, 9, "Control group" ], [ 16, 17, "Data source" ], [ 21, 22, "Geographic location" ], [ 30, 30, "Matching criterion" ], [ 32, 32, "Matching criterion" ] ]
[ "Osimertinib", ",", "an", "irreversible", "epidermal", "growth", "factor", "receptor", "tyrosine", "kinase", "inhibitor", "(", "EGFR", "-", "TKI", ")", "used", "for", "cancer", "treatment", ",", "can", "cause", "significant", "cardiac", "toxicity", ".", "However...	[ [ 0, 0, "Drug" ], [ 33, 33, "Drug" ], [ 48, 48, "Drug" ], [ 111, 111, "Drug" ], [ 156, 156, "Drug" ], [ 172, 172, "Drug" ], [ 200, 200, "Drug" ], [ 4, 15, "Drug class" ], [ 18, 19,...
[ "BACKGROUND", ":", "Neonates", "with", "intrauterine", "growth", "retardation", "(", "IUGR", ")", "may", "present", "with", "fatal", "complications", "and", "permanent", "serious", "consequences", ".", "Vitamin", "status", "may", "influence", "fetal", "development",...	[ [ 2, 2, "Patient group" ], [ 172, 172, "Patient group" ], [ 218, 218, "Patient group" ], [ 234, 234, "Patient group" ], [ 330, 330, "Patient group" ], [ 346, 346, "Patient group" ], [ 4, 18, "Condition" ], ...
[ "Fortification", "adjusted", "according", "to", "urea", "with", "FM", "85", "at", "4", "%", "and", "oligopeptides", ".", "In", "this", "arm", ",", "fortification", "at", "4", "%", "is", "started", ",", "and", "according", "to", "plasma", "urea", "control",...	[ [ 0, 0, "Medical intervention" ], [ 18, 18, "Medical intervention" ], [ 35, 35, "Medical intervention" ], [ 4, 4, "Biomarker" ], [ 29, 29, "Biomarker" ], [ 6, 7, "Nutrient" ], [ 12, 12, "Nutrient" ], [ ...
[ "Average", "plasma", "concentrations", "(", "mcg", "/", "mL", ")", "of", "ertapenem", "following", "a", "single", "30", "-", "minute", "infusion", "of", "a", "1", "g", "intravenous", "(", "I.V.", ")", "dose", "and", "administration", "of", "a", "single", ...	[ [ 9, 9, "Drug" ], [ 62, 62, "Drug" ], [ 75, 75, "Drug" ], [ 99, 99, "Drug" ], [ 102, 102, "Drug" ], [ 135, 135, "Drug" ], [ 159, 159, "Drug" ], [ 172, 172, "Drug" ], [ 242, 242, ...
[ "The", "invention", "discloses", "a", "medicine", "containing", "amlodipine", "besylate", "and", "lisinopril", "dehydrate", "and", "a", "preparation", "method", "thereof", ".", "Per", "unit", "of", "the", "preparation", "is", "composed", "of", ",", "by", "weight...	[ [ 4, 4, "Drug product" ], [ 74, 74, "Drug product" ], [ 121, 121, "Drug product" ], [ 186, 186, "Drug product" ], [ 6, 7, "Active pharmaceutical ingredient" ], [ 34, 35, "Active pharmaceutical ingredient" ], [ 112, ...
[ "The", "dofetilide", "clinical", "program", "involved", "approximately", "8,600", "patients", "in", "130", "clinical", "studies", "of", "normal", "volunteers", "and", "patients", "with", "supraventricular", "and", "ventricular", "arrhythmias", ".", "Dofetilide", "was"...	[ [ 1, 1, "Drug" ], [ 23, 23, "Drug" ], [ 51, 51, "Drug" ], [ 143, 143, "Drug" ], [ 164, 164, "Drug" ], [ 202, 202, "Drug" ], [ 6, 7, "Patient population" ], [ 9, 11, "Clinical trials" ], [ ...
[ "The", "aim", "of", "this", "study", "was", "to", "explore", "psychiatric", "nurse", "'s", "experiences", "of", "caring", "for", "people", "with", "auditory", "hallucinations", "in", "an", "acute", "unit", ".", "A", "qualitative", "study", "was", "conducted", ...	[ [ 8, 9, "Professional" ], [ 11, 11, "Emotion" ], [ 13, 18, "Activity" ], [ 21, 22, "Location" ], [ 42, 43, "Location" ], [ 69, 70, "Location" ], [ 109, 110, "Location" ], [ 137, 138, "Location...
[ "Induction", "will", "consist", "of", "tretinoin", "45", "mg", "/", "m2", "po", "daily", "(", "rounded", "up", "to", "the", "nearest", "10", "mg", ")", "in", "two", "divided", "doses", "(", "25", "mg", "/", "m2", "in", "patients", "\\<20", "years", "...	[ [ 4, 4, "Drug" ], [ 182, 182, "Drug" ], [ 273, 273, "Drug" ], [ 289, 289, "Drug" ], [ 5, 8, "Dosage" ], [ 183, 186, "Dosage" ], [ 290, 293, "Dosage" ], [ 9, 9, "Route of administration" ], ...
[ "Skin", "fibrosis", "is", "a", "significant", "global", "health", "problem", "that", "has", "a", "profoundly", "negative", "impact", "on", "quality", "of", "life", ".", "Characterized", "by", "excessive", "fibroblast", "proliferation", "and", "collagen", "depositi...	[ [ 0, 1, "Condition" ], [ 28, 29, "Condition" ], [ 80, 81, "Condition" ], [ 101, 102, "Condition" ], [ 5, 7, "Classification" ], [ 15, 17, "Outcome" ], [ 21, 23, "Pathological process" ], [ 25, 26,...
[ "INTRODUCTION", ":", "Poststroke", "shoulder", "pain", "is", "a", "common", "complication", "that", "severely", "affects", "the", "recovery", "of", "upper", "limb", "motor", "function", ".", "Acupuncture", "has", "positive", "analgesic", "effects", "in", "treating...	[ [ 2, 4, "Condition" ], [ 27, 29, "Condition" ], [ 65, 67, "Condition" ], [ 83, 85, "Condition" ], [ 20, 20, "Treatment" ], [ 55, 55, "Treatment" ], [ 132, 132, "Treatment" ], [ 138, 138, "Trea...
[ "The", "combination", "of", "promethazine", "hydrochloride", "and", "codeine", "phosphate", "is", "contraindicated", "in", "pediatric", "patients", "less", "than", "6", "years", "of", "age", ",", "because", "the", "combination", "may", "cause", "fatal", "respirato...	[ [ 3, 4, "Drug" ], [ 6, 7, "Drug" ], [ 11, 12, "Patient group" ], [ 15, 18, "Age group" ], [ 25, 27, "Adverse event" ], [ 54, 55, "Measuring device" ], [ 66, 66, "Adverse event" ], [ 46, 48, "M...
[ "Dorzolamide", "Hydrochloride", "-", "Timolol", "Maleate", "Ophthalmic", "Solution", "is", "an", "eyedrop", ".", "The", "usual", "dose", "is", "one", "drop", "in", "the", "morning", "and", "one", "drop", "in", "the", "evening", ".", "Your", "doctor", "will",...	[ [ 0, 6, "Drug" ], [ 47, 53, "Drug" ], [ 96, 102, "Drug" ], [ 127, 133, "Drug" ], [ 9, 9, "Drug form" ], [ 56, 56, "Drug form" ], [ 15, 16, "Dosage" ], [ 21, 22, "Dosage" ], [ 19, 1...
[ "Take", "deferasirox", "oral", "granules", "on", "an", "empty", "stomach", "or", "with", "a", "light", "meal", "(", "contains", "less", "than", "7", "%", "fat", "content", "and", "approximately", "250", "calories", ")", ".", "Examples", "of", "light", "mea...	[ [ 1, 3, "Drug product" ], [ 87, 89, "Drug product" ], [ 113, 115, "Drug product" ], [ 134, 136, "Drug product" ], [ 170, 172, "Drug product" ], [ 6, 7, "Condition" ], [ 11, 12, "Condition" ], [ 17, ...
[ "Continuous", "glucose", "monitors", "will", "be", "fitted", "for", "7", "days", ",", "along", "with", "activity", "trackers", "and", "a", "food", "diary", "to", "monitor", "the", "impact", "of", "these", "factors", "on", "blood", "glucose", "concentrations", ...	[ [ 0, 2, "Device" ], [ 7, 8, "Duration" ], [ 12, 13, "Device" ], [ 16, 17, "Tool" ], [ 26, 28, "Measurement" ], [ 30, 30, "Study subject" ], [ 34, 34, "Tool" ], [ 37, 38, "Concept" ], [ ...
[ "The", "effectiveness", "of", "LAMICTAL", "XR", "as", "monotherapy", "for", "partial", "-", "onset", "seizures", "was", "established", "in", "a", "historical", "control", "trial", "in", "223", "adults", "with", "partial", "-", "onset", "seizures", ".", "The", ...	[ [ 3, 4, "Drug" ], [ 64, 65, "Drug" ], [ 147, 148, "Drug" ], [ 220, 221, "Drug" ], [ 260, 261, "Drug" ], [ 8, 11, "Condition" ], [ 23, 26, "Condition" ], [ 182, 185, "Condition" ], [ 16...
[ "Hwato", "brand", "disposable", "placebo", "needles", "(", "with", "the", "handle", "identical", "to", "the", "needles", "in", "the", "acupuncture", "group", "and", "the", "body", "at", "a", "size", "0.30", "×", "25", "mm", ")", "and", "adhesive", "pads", ...	[ [ 0, 4, "Medical device" ], [ 15, 16, "Study group" ], [ 86, 87, "Study group" ], [ 8, 8, "Component" ], [ 19, 19, "Component" ], [ 22, 26, "Specification" ], [ 29, 30, "Medical device" ], [ 38, 4...
[ "A", "method", "is", "disclosed", "for", "manufacturing", "or", "processing", "a", "radiopharmaceutical", "composition", ".", "The", "composition", "is", "an", "emitter", "of", "charged", "antiparticles", "such", "as", "positrons", ".", "A", "pixelated", "detector...	[ [ 1, 1, "Patent component" ], [ 106, 106, "Patent component" ], [ 9, 10, "Substance" ], [ 66, 67, "Substance" ], [ 76, 77, "Substance" ], [ 111, 112, "Substance" ], [ 119, 120, "Substance" ], [ 130, ...
[ "Patients", "with", "lung", "adenocarcinoma", "(", "LUAD", ")", "generally", "have", "poor", "prognosis", ".", "Abnormal", "cellular", "energy", "metabolism", "is", "a", "hallmark", "of", "LUAD", ".", "Glutathione", "-", "specific", "gamma", "-", "glutamylcyclot...	[ [ 2, 6, "Disease" ], [ 22, 31, "Gene" ], [ 37, 40, "Gene family" ], [ 43, 46, "Biological pathway" ], [ 14, 15, "Biological process" ], [ 60, 61, "Biological process" ], [ 237, 238, "Biological process" ], ...
[ "BACKGROUND", ":", "Most", "studies", "on", "tumour", "progression", "from", "precursor", "lesion", "toward", "gallbladder", "adenocarcinoma", "investigate", "lesions", "sampled", "from", "distinct", "patients", ",", "providing", "an", "overarching", "view", "of", "...	[ [ 5, 6, "Biological process" ], [ 304, 305, "Biological process" ], [ 391, 392, "Biological process" ], [ 8, 9, "Biological entity" ], [ 11, 12, "Disease" ], [ 357, 358, "Disease" ], [ 43, 44, "Research metho...
[ "The", "aim", "of", "this", "Phase", "III", ",", "randomized", ",", "double", "-", "blind", ",", "placebo", "-", "controlled", ",", "parallel", "-", "group", "study", "is", "to", "evaluate", "the", "efficacy", "and", "safety", "of", "denosumab", "(", "DM...	[ [ 4, 5, "Study phase" ], [ 7, 7, "Study characteristic" ], [ 74, 74, "Study characteristic" ], [ 9, 11, "Study characteristic" ], [ 58, 60, "Study characteristic" ], [ 77, 79, "Study characteristic" ], [ 115, 117...
[ "Background", ":", "Glioblastoma", "(", "GBM", ")", "is", "the", "most", "common", "malignant", "glioma", "in", "adults", ",", "with", "a", "very", "poor", "prognosis", ",", "limited", "new", "treatment", "options", ",", "and", "neurological", "sequelae", ",...	[ [ 2, 5, "Condition" ], [ 10, 11, "Condition" ], [ 13, 13, "Population" ], [ 18, 19, "Outcome" ], [ 21, 24, "Outcome" ], [ 27, 28, "Outcome" ], [ 56, 57, "Outcome" ], [ 33, 34, "Outcome" ], ...
[ "PURPOSE", ":", "To", "make", "it", "possible", "to", "use", "a", "compd", ".", "as", "an", "ultraviolet", "absorber", "and", "to", "improve", "water", "-", "solubility", ",", "by", "reacting", "a", "part", "of", "amino", "acids", "constituting", "a", "p...	[ [ 9, 9, "Chemical compound" ], [ 13, 14, "Chemical role" ], [ 166, 167, "Chemical role" ], [ 18, 20, "Property" ], [ 27, 28, "Chemical compound" ], [ 151, 152, "Chemical compound" ], [ 31, 32, "Chemical compo...
[ "A", "control", "group", "composed", "of", "women", "with", "normal", "ovarian", "reserve", "(", "30", "to", "45", "yerras", "old", ")", "is", "needed", "to", "compare", "telomeric", "and", "fertility", "parameters", "with", "the", "group", "of", "women", ...	[ [ 1, 2, "Study group" ], [ 96, 97, "Study group" ], [ 5, 5, "Demographic" ], [ 29, 29, "Demographic" ], [ 47, 47, "Demographic" ], [ 49, 49, "Demographic" ], [ 87, 87, "Demographic" ], [ 93, 93, ...
[ "Advise", "patients", "to", "hydrate", "adequately", "before", ",", "during", ",", "and", "after", "the", "use", "of", "polyethylene", "glycol", "3350", ",", "sodium", "chloride", ",", "sodium", "bicarbonate", "and", "potassium", "chloride", "for", "oral", "so...	[ [ 14, 28, "Drug" ], [ 59, 73, "Drug" ], [ 123, 137, "Drug" ], [ 147, 161, "Drug" ], [ 1, 1, "Patient" ], [ 33, 33, "Patient" ], [ 163, 163, "Patient" ], [ 35, 37, "Condition" ], [ 47, ...
[ "Fenofibrate", ",", "is", "a", "lipid", "regulating", "agent", "available", "as", "capsules", "for", "oral", "administration", ".", "Each", "capsule", "contains", "43", "mg", "or", "130", "mg", "of", "micronized", "fenofibrate", ".", "The", "chemical", "name",...	[ [ 0, 0, "Drug" ], [ 24, 24, "Drug" ], [ 30, 30, "Drug" ], [ 54, 54, "Drug" ], [ 68, 68, "Drug" ], [ 84, 84, "Drug" ], [ 9, 9, "Dosage form" ], [ 122, 122, "Dosage form" ], [ 11, 12...
[ "Intravitreal", "injection", "of", "medicine", "has", "become", "the", "most", "common", "ocular", "procedure", "billed", "to", "Medicare", ".", "One", "of", "the", "main", "problems", "with", "this", "procedure", "is", "the", "postoperative", "discomfort", "due...	[ [ 0, 1, "Medical procedure" ], [ 151, 152, "Medical procedure" ], [ 217, 218, "Medical procedure" ], [ 3, 3, "Substance" ], [ 36, 40, "Substance" ], [ 25, 26, "Symptom" ], [ 56, 57, "Anatomical structure" ]...
[ "Hypertension", "occurred", "in", "44", "%", "of", "patients", "in", "Study", "201", "and", "28", "%", "of", "patients", "in", "Study", "12", "-", "230", "who", "received", "DANYELZA", ".", "Grade", "3", "or", "4", "hypertension", "occurred", "in", "4", ...	[ [ 0, 0, "Adverse Event" ], [ 28, 28, "Adverse Event" ], [ 64, 64, "Adverse Event" ], [ 100, 100, "Adverse Event" ], [ 127, 127, "Adverse Event" ], [ 8, 9, "Clinical Trial" ], [ 36, 37, "Clinical Trial" ], ...
[ "The", "recommended", "dosage", "of", "KISUNLA", "is", "700", "mg", "every", "four", "weeks", "for", "three", "doses", ",", "then", "1400", "mg", "every", "four", "weeks", "(", "see", "Table", "1", ")", ".", "KISUNLA", "is", "administered", "every", "fou...	[ [ 4, 4, "Drug" ], [ 27, 27, "Drug" ], [ 42, 42, "Drug" ], [ 60, 60, "Drug" ], [ 6, 7, "Dosage" ], [ 8, 10, "Frequency" ], [ 18, 20, "Frequency" ], [ 30, 32, "Frequency" ], [ 12, 13...
[ "The", "MRP", "comprises", "of", "3", "-", "4", "meals", "a", "day", "(", "850kcal", "/", "day", ")", "supplied", "by", "Counterweight", ".", "Participants", "will", "be", "supported", "by", "professional", "research", "dieticians", ",", "and", "a", "study...	[ [ 1, 1, "Medical intervention" ], [ 4, 9, "Meal pattern" ], [ 11, 13, "Caloric intake" ], [ 17, 17, "Supplementary entity" ], [ 24, 26, "Support personnel" ], [ 30, 31, "Support personnel" ], [ 33, 34, "Healt...
[ "This", "is", "a", "single", "arm", "study", "with", "two", "stage", "design", "using", "nivolumab", "in", "advanced", "biliary", "tract", "cancer", "(", "BTC", ")", ",", "for", "participants", "who", "have", "failed", "or", "are", "intolerant", "to", "at"...	[ [ 11, 11, "Drug" ], [ 13, 19, "Condition" ], [ 22, 22, "Study subject" ], [ 51, 51, "Study subject" ], [ 66, 66, "Study subject" ], [ 33, 35, "Treatment" ], [ 47, 48, "Study phase" ], [ 50, 51, ...
[ "Placebo", ":", "A", "normal", "saline", "infusion", ".", "This", "is", "the", "placebo", "intervention", "to", "occur", "at", "surgery", "and", "day", "4", "post", "-", "transplant", ".", "The", "infusion", "set", "-", "up", "will", "be", "covered", "to...	[ [ 0, 0, "Intervention" ], [ 10, 10, "Intervention" ], [ 3, 5, "Substance" ], [ 15, 15, "Event" ], [ 68, 68, "Event" ], [ 17, 21, "Time point" ], [ 41, 43, "Drug" ], [ 53, 62, "Dosage" ], [...
[ "As", "with", "all", "therapeutic", "proteins", ",", "there", "is", "potential", "for", "immunogenicity", ".", "The", "detection", "of", "antibody", "formation", "is", "highly", "dependent", "on", "the", "sensitivity", "and", "specificity", "of", "the", "assay",...	[ [ 3, 4, "Drug class" ], [ 10, 10, "Adverse drug event" ], [ 15, 16, "Biological process" ], [ 27, 27, "Medical test" ], [ 44, 44, "Medical test" ], [ 52, 52, "Medical test" ], [ 22, 22, "Assay characteristic"...
[ "Pneumococcal", "disease", "is", "a", "major", "source", "of", "morbidity", "and", "mortality", "in", "HIV", "-", "patients", ".", "HIV", "-", "patients", "are", "vaccine", "hyporesponders", ".", "A", "good", "immune", "response", "to", "pneumococcal", "vaccin...	[ [ 0, 1, "Disease" ], [ 41, 42, "Disease" ], [ 11, 13, "Patient group" ], [ 15, 17, "Patient group" ], [ 19, 20, "Vaccine response" ], [ 27, 28, "Vaccine" ], [ 114, 115, "Vaccine" ], [ 24, 25, ...
[ "#", "#", "#", "Risk", "Summary", "\n\n", "Based", "on", "data", "from", "animal", "reproduction", "studies", ",", "Adempas", "may", "cause", "embryo", "-", "fetal", "toxicity", "and", "miscarriage", "when", "administered", "to", "a", "pregnant", "woman", "a...	[ [ 14, 14, "Drug" ], [ 48, 48, "Drug" ], [ 27, 28, "Patient" ], [ 17, 20, "Adverse effect" ], [ 22, 22, "Adverse effect" ], [ 146, 146, "Adverse effect" ], [ 186, 186, "Adverse effect" ], [ 36, 36,...
[ "After", "final", "irrigation", "was", "performed", "using", "5ml", "2.5", "%", "NaOCI", ",", "followed", "by", "5", "ml", "17", "%", "EDTA", "for", "3", "min", "and", "5", "ml", "distilled", "water", ",", "root", "canals", "were", "irradiated", "with", ...	[ [ 1, 2, "Procedure" ], [ 6, 9, "Irrigant" ], [ 13, 17, "Irrigant" ], [ 22, 25, "Irrigant" ], [ 32, 35, "Device" ], [ 38, 41, "Device" ], [ 46, 50, "Setting" ], [ 52, 53, "Setting" ], [ ...
[ "Automatic", "seizure", "detection", "has", "significant", "value", "in", "epilepsy", "diagnosis", "and", "treatment", ".", "Although", "a", "variety", "of", "deep", "learning", "models", "have", "been", "proposed", "to", "automatically", "learn", "electroencephalog...	[ [ 0, 2, "Medical procedure" ], [ 7, 8, "Medical procedure" ], [ 10, 10, "Medical procedure" ], [ 16, 18, "Machine learning model" ], [ 25, 29, "Medical data" ], [ 1, 2, "Medical procedure" ], [ 31, 32, "Medic...
[ "Intensive", "Lifestyle", "Intervention", "at", "Ubberup", "Folk", "High", "School", "for", "10", "-", "14", "weeks", ".", "Daily", "exercise", "for", "1", "-", "3hrs", ".", "Calorie", "restriction", "(", "\\~-700KCal", "/", "day", ")", ".", "Education", "...	[ [ 0, 2, "Program" ], [ 4, 7, "Location" ], [ 9, 12, "Duration" ], [ 14, 15, "Activity" ], [ 17, 19, "Duration" ], [ 21, 22, "Activity" ], [ 29, 29, "Activity" ], [ 31, 31, "Topic" ], [ ...
[ "Stroke", "is", "a", "common", ",", "serious", "and", "restrictive", "global", "health", "problem", ".", "In", "most", "countries", ",", "stroke", "is", "among", "the", "second", "or", "third", "most", "common", "cause", "of", "death", "and", "is", "one", ...	[ [ 0, 0, "Condition" ], [ 16, 16, "Condition" ], [ 50, 50, "Condition" ], [ 78, 78, "Condition" ], [ 83, 83, "Condition" ], [ 100, 100, "Condition" ], [ 124, 124, "Condition" ], [ 144, 144, "Co...
[ "Stomach", "cancer", "is", "the", "second", "most", "common", "cause", "of", "cancer", "death", ".", "Endoscopic", "identification", "and", "treatment", "of", "gastric", "intestinal", "metaplasia", "(", "GIM", ")", "and", "early", "gastric", "cancer", "(", "EG...	[ [ 0, 1, "Disease" ], [ 17, 22, "Condition" ], [ 24, 29, "Condition" ], [ 42, 43, "Medical procedure" ], [ 45, 50, "Medical imaging technique" ], [ 55, 56, "Medical procedure" ], [ 36, 40, "Outcome measure" ...
[ "Despite", "antiretroviral", "therapy", "(", "ART", ")", ",", "HIV", "persists", "in", "latently", "-", "infected", "cells", "(", "the", "HIV", "reservoir", ")", "which", "decay", "slowly", "over", "time", ".", "Here", ",", "leveraging", ">", "500", "longi...	[ [ 1, 5, "Treatment" ], [ 7, 7, "Pathogen" ], [ 16, 16, "Pathogen" ], [ 37, 37, "Pathogen" ], [ 182, 182, "Pathogen" ], [ 10, 13, "Cell type" ], [ 16, 17, "Pathogen reservoir" ], [ 182, 183, "P...
[ "Storage", "of", "the", "solution", "for", "injection", "at", "refrigerated", "conditions", "can", "result", "in", "the", "formation", "of", "a", "gelled", "product", ".", "This", "gelled", "product", "will", "return", "to", "a", "slightly", "viscous", "to", ...	[ [ 88, 90, "Drug" ], [ 123, 125, "Drug" ], [ 167, 169, "Drug" ], [ 354, 356, "Drug" ], [ 372, 374, "Drug" ], [ 404, 406, "Drug" ], [ 447, 449, "Drug" ], [ 462, 464, "Drug" ], [ 476, ...
[ "This", "is", "an", "open", "label", "pilot", "study", "to", "evaluate", "the", "safety", ",", "tolerability", ",", "and", "efficacy", "of", "the", "combination", "of", "Vigil", "autologous", "tumor", "cell", "immunotherapy", "and", "durvalumab", "PD", "-", ...	[ [ 20, 24, "Treatment" ], [ 26, 30, "Treatment" ], [ 38, 40, "Condition" ], [ 48, 48, "Condition" ], [ 50, 50, "Condition" ], [ 52, 52, "Condition" ], [ 54, 54, "Condition" ], [ 56, 56, "Condit...

End of preview. Expand in Data Studio

GLiNER-BioMed pre-training dataset

This dataset, used for the pre-training stage of the GLiNER-BioMed models, was introduced in the paper GLiNER-BioMed: a suite of efficient models for open biomedical named entity recognition.

Citation

If you use the GLiNER-BioMed models or datasets in your work, please cite:

@article{yazdani2026gliner,
    author = {Yazdani, Anthony and Stepanov, Ihor and Teodoro, Douglas},
    title = {{GLiNER-BioMed}: a suite of efficient models for open biomedical named entity recognition},
    journal = {Bioinformatics},
    volume = {42},
    number = {6},
    pages = {btag322},
    year = {2026},
    month = jun,
    issn = {1367-4811},
    doi = {10.1093/bioinformatics/btag322},
    url = {https://doi.org/10.1093/bioinformatics/btag322}
}

Downloads last month: 41

Models trained or fine-tuned on anthonyyazdaniml/gliner-biomed-pre-training